 | • レポートコード：MRC2012A4391 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、心不全治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。心不全治療薬の種類別市場規模（ACEI、アンジオテンシンII受容体遮断薬、ARNI、ベータ遮断薬、アルドステロン拮抗薬、利尿薬）、用途別市場規模（駆出率低下、駆出率維持）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Novartis、Amgen、Hikma、Pfizer、Merck & Co.、AstraZeneca、Sun Pharma、Cipla、Teva、Roche、Mylan、 ・地域別グローバル市場分析 2015年-2020年 ・心不全治療薬の北米市場（アメリカ、カナダ、メキシコ） ・心不全治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・心不全治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・心不全治療薬の南米市場（ブラジル、アルゼンチン） ・心不全治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ACEI、アンジオテンシンII受容体遮断薬、ARNI、ベータ遮断薬、アルドステロン拮抗薬、利尿薬 ・用途別分析：駆出率低下、駆出率維持 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Heart Failure Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Heart Failure Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Heart Failure Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Heart Failure Drugs market has been segmented into
ACEI
Angiotensin II Receptor Blockers
ARNIs
Beta Blockers
Aldosterone Antagonists
Diuretics
By Application, Heart Failure Drugs has been segmented into:
Reduced Ejection Fraction
Preserved Ejection Fraction
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Heart Failure Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Heart Failure Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Heart Failure Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Heart Failure Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Heart Failure Drugs Market Share Analysis
Heart Failure Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Heart Failure Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Heart Failure Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Heart Failure Drugs are:
Novartis
Amgen
Hikma
Pfizer
Merck & Co.
AstraZeneca
Sun Pharma
Cipla
Teva
Roche
Mylan
Among other players domestic and global, Heart Failure Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Heart Failure Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Heart Failure Drugs, with price, sales, revenue and global market share of Heart Failure Drugs in 2018 and 2019.
Chapter 3, the Heart Failure Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Heart Failure Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Heart Failure Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Heart Failure Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Heart Failure Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Heart Failure Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 ACEI
1.2.3 Angiotensin II Receptor Blockers
1.2.4 ARNIs
1.2.5 Beta Blockers
1.2.6 Aldosterone Antagonists
1.2.7 Diuretics
1.3 Market Analysis by Application
1.3.1 Overview: Global Heart Failure Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Reduced Ejection Fraction
1.3.3 Preserved Ejection Fraction
1.4 Overview of Global Heart Failure Drugs Market
1.4.1 Global Heart Failure Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novartis
2.1.1 Novartis Details
2.1.2 Novartis Major Business
2.1.3 Novartis SWOT Analysis
2.1.4 Novartis Product and Services
2.1.5 Novartis Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Amgen
2.2.1 Amgen Details
2.2.2 Amgen Major Business
2.2.3 Amgen SWOT Analysis
2.2.4 Amgen Product and Services
2.2.5 Amgen Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Hikma
2.3.1 Hikma Details
2.3.2 Hikma Major Business
2.3.3 Hikma SWOT Analysis
2.3.4 Hikma Product and Services
2.3.5 Hikma Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck & Co.
2.5.1 Merck & Co. Details
2.5.2 Merck & Co. Major Business
2.5.3 Merck & Co. SWOT Analysis
2.5.4 Merck & Co. Product and Services
2.5.5 Merck & Co. Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business
2.6.3 AstraZeneca Product and Services
2.6.4 AstraZeneca Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sun Pharma
2.7.1 Sun Pharma Details
2.7.2 Sun Pharma Major Business
2.7.3 Sun Pharma Product and Services
2.7.4 Sun Pharma Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Cipla
2.8.1 Cipla Details
2.8.2 Cipla Major Business
2.8.3 Cipla Product and Services
2.8.4 Cipla Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Teva
2.9.1 Teva Details
2.9.2 Teva Major Business
2.9.3 Teva Product and Services
2.9.4 Teva Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Roche
2.10.1 Roche Details
2.10.2 Roche Major Business
2.10.3 Roche Product and Services
2.10.4 Roche Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Mylan
2.11.1 Mylan Details
2.11.2 Mylan Major Business
2.11.3 Mylan Product and Services
2.11.4 Mylan Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Heart Failure Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Heart Failure Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Heart Failure Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Heart Failure Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Heart Failure Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Heart Failure Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Heart Failure Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Heart Failure Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Heart Failure Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Heart Failure Drugs Sales and Growth Rate (2015-2020)
4.5 South America Heart Failure Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Heart Failure Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Heart Failure Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Heart Failure Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Heart Failure Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Heart Failure Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Heart Failure Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Heart Failure Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Heart Failure Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Heart Failure Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Heart Failure Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Heart Failure Drugs Sales and Growth Rate (2015-2020)
6.3 UK Heart Failure Drugs Sales and Growth Rate (2015-2020)
6.4 France Heart Failure Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Heart Failure Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Heart Failure Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Heart Failure Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Heart Failure Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Heart Failure Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Heart Failure Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Heart Failure Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Heart Failure Drugs Sales and Growth Rate (2015-2020)
7.5 India Heart Failure Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Heart Failure Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Heart Failure Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Heart Failure Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Heart Failure Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Heart Failure Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Heart Failure Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Heart Failure Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Heart Failure Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Heart Failure Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Heart Failure Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Heart Failure Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Heart Failure Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Heart Failure Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Heart Failure Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Heart Failure Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Heart Failure Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Heart Failure Drugs Price by Type (2015-2020)
11 Global Heart Failure Drugs Market Segment by Application
11.1 Global Heart Failure Drugs Sales Market Share by Application (2015-2020)
11.2 Global Heart Failure Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Heart Failure Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Heart Failure Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Heart Failure Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Heart Failure Drugs Market Forecast (2021-2025)
12.2.2 Europe Heart Failure Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Heart Failure Drugs Market Forecast (2021-2025)
12.2.4 South America Heart Failure Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Heart Failure Drugs Market Forecast (2021-2025)
12.3 Heart Failure Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Heart Failure Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Heart Failure Drugs Market Share Forecast by Type (2021-2025)
12.4 Heart Failure Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Heart Failure Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Heart Failure Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Heart Failure Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Heart Failure Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Heart Failure Drugs Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Heart Failure Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Novartis Basic Information, Manufacturing Base and Competitors
Table 9. Novartis Heart Failure Drugs Major Business
Table 10. Novartis Heart Failure Drugs Total Revenue (USD Million) (2018-2019)
Table 11. Novartis SWOT Analysis
Table 12. Novartis Heart Failure Drugs Product and Services
Table 13. Novartis Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Amgen Basic Information, Manufacturing Base and Competitors
Table 15. Amgen Heart Failure Drugs Major Business
Table 16. Amgen Heart Failure Drugs Total Revenue (USD Million) (2018-2019)
Table 17. Amgen SWOT Analysis
Table 18. Amgen Heart Failure Drugs Product and Services
Table 19. Amgen Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Hikma Basic Information, Manufacturing Base and Competitors
Table 21. Hikma Heart Failure Drugs Major Business
Table 22. Hikma Heart Failure Drugs Total Revenue (USD Million) (2018-2019)
Table 23. Hikma SWOT Analysis
Table 24. Hikma Heart Failure Drugs Product and Services
Table 25. Hikma Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Pfizer Basic Information, Manufacturing Base and Competitors
Table 27. Pfizer Heart Failure Drugs Major Business
Table 28. Pfizer Heart Failure Drugs Total Revenue (USD Million) (2018-2019)
Table 29. Pfizer SWOT Analysis
Table 30. Pfizer Heart Failure Drugs Product and Services
Table 31. Pfizer Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 33. Merck & Co. Heart Failure Drugs Major Business
Table 34. Merck & Co. Heart Failure Drugs Total Revenue (USD Million) (2018-2019)
Table 35. Merck & Co. SWOT Analysis
Table 36. Merck & Co. Heart Failure Drugs Product and Services
Table 37. Merck & Co. Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 39. AstraZeneca Heart Failure Drugs Major Business
Table 40. AstraZeneca Heart Failure Drugs Total Revenue (USD Million) (2018-2019)
Table 41. AstraZeneca SWOT Analysis
Table 42. AstraZeneca Heart Failure Drugs Product and Services
Table 43. AstraZeneca Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 45. Sun Pharma Heart Failure Drugs Major Business
Table 46. Sun Pharma Heart Failure Drugs Total Revenue (USD Million) (2018-2019)
Table 47. Sun Pharma SWOT Analysis
Table 48. Sun Pharma Heart Failure Drugs Product and Services
Table 49. Sun Pharma Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Cipla Basic Information, Manufacturing Base and Competitors
Table 51. Cipla Heart Failure Drugs Major Business
Table 52. Cipla Heart Failure Drugs Total Revenue (USD Million) (2018-2019)
Table 53. Cipla SWOT Analysis
Table 54. Cipla Heart Failure Drugs Product and Services
Table 55. Cipla Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Teva Basic Information, Manufacturing Base and Competitors
Table 57. Teva Heart Failure Drugs Major Business
Table 58. Teva Heart Failure Drugs Total Revenue (USD Million) (2018-2019)
Table 59. Teva SWOT Analysis
Table 60. Teva Heart Failure Drugs Product and Services
Table 61. Teva Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Roche Basic Information, Manufacturing Base and Competitors
Table 63. Roche Heart Failure Drugs Major Business
Table 64. Roche Heart Failure Drugs Total Revenue (USD Million) (2018-2019)
Table 65. Roche SWOT Analysis
Table 66. Roche Heart Failure Drugs Product and Services
Table 67. Roche Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Mylan Basic Information, Manufacturing Base and Competitors
Table 69. Mylan Heart Failure Drugs Major Business
Table 70. Mylan Heart Failure Drugs Total Revenue (USD Million) (2018-2019)
Table 71. Mylan SWOT Analysis
Table 72. Mylan Heart Failure Drugs Product and Services
Table 73. Mylan Heart Failure Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. Global Heart Failure Drugs Sales by Manufacturer (2018-2019) (MT)
Table 75. Global Heart Failure Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 76. Global Heart Failure Drugs Sales by Regions (2015-2020) (MT)
Table 77. Global Heart Failure Drugs Sales Market Share by Regions (2015-2020)
Table 78. Global Heart Failure Drugs Revenue by Regions (2015-2020) (USD Million)
Table 79. North America Heart Failure Drugs Sales by Countries (2015-2020) (MT)
Table 80. North America Heart Failure Drugs Sales Market Share by Countries (2015-2020)
Table 81. North America Heart Failure Drugs Revenue by Countries (2015-2020) (USD Million)
Table 82. North America Heart Failure Drugs Revenue Market Share by Countries (2015-2020)
Table 83. Europe Heart Failure Drugs Sales by Countries (2015-2020) (MT)
Table 84. Europe Heart Failure Drugs Sales Market Share by Countries (2015-2020)
Table 85. Europe Heart Failure Drugs Revenue by Countries (2015-2020) (USD Million)
Table 86. Asia-Pacific Heart Failure Drugs Sales by Regions (2015-2020) (MT)
Table 87. Asia-Pacific Heart Failure Drugs Sales Market Share by Regions (2015-2020)
Table 88. Asia-Pacific Heart Failure Drugs Revenue by Regions (2015-2020) (USD Million)
Table 89. South America Heart Failure Drugs Sales by Countries (2015-2020) (MT)
Table 90. South America Heart Failure Drugs Sales Market Share by Countries (2015-2020)
Table 91. South America Heart Failure Drugs Revenue by Countries (2015-2020) (USD Million)
Table 92. South America Heart Failure Drugs Revenue Market Share by Countries (2015-2020)
Table 93. Middle East & Africa Heart Failure Drugs Sales by Countries (2015-2020) (MT)
Table 94. Middle East & Africa Heart Failure Drugs Sales Market Share by Countries (2015-2020)
Table 95. Middle East & Africa Heart Failure Drugs Revenue by Countries (2015-2020) (USD Million)
Table 96. Middle East & Africa Heart Failure Drugs Revenue Market Share by Countries (2015-2020)
Table 97. Global Heart Failure Drugs Sales by Type (2015-2020) (MT)
Table 98. Global Heart Failure Drugs Sales Share by Type (2015-2020)
Table 99. Global Heart Failure Drugs Revenue by Type (2015-2020) (USD Million)
Table 100. Global Heart Failure Drugs Revenue Share by Type (2015-2020)
Table 101. Global Heart Failure Drugs Sales by Application (2015-2020) (MT)
Table 102. Global Heart Failure Drugs Sales Share by Application (2015-2020)
Table 103. Global Heart Failure Drugs Sales Forecast by Regions (2021-2025) (MT)
Table 104. Global Heart Failure Drugs Market Share Forecast by Regions (2021-2025)
Table 105. Global Heart Failure Drugs Sales Forecast by Type (2021-2025) (MT)
Table 106. Global Heart Failure Drugs Market Share Forecast by Type (2021-2025)
Table 107. Global Heart Failure Drugs Sales Forecast by Application (2021-2025)
Table 108. Global Heart Failure Drugs Market Share Forecast by Application (2021-2025)
Table 109. Direct Channel Pros & Cons
Table 110. Indirect Channel Pros & Cons
Table 111. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Heart Failure Drugs Picture
Figure 2. Global Sales Market Share of Heart Failure Drugs by Type in 2019
Figure 3. ACEI Picture
Figure 4. Angiotensin II Receptor Blockers Picture
Figure 5. ARNIs Picture
Figure 6. Beta Blockers Picture
Figure 7. Aldosterone Antagonists Picture
Figure 8. Diuretics Picture
Figure 9. Heart Failure Drugs Sales Market Share by Application in 2019
Figure 10. Reduced Ejection Fraction Picture
Figure 11. Preserved Ejection Fraction Picture
Figure 12. Global Heart Failure Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Heart Failure Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Heart Failure Drugs Sales Market Share by Manufacturer in 2019
Figure 33. Global Heart Failure Drugs Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Heart Failure Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Heart Failure Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 38. Global Heart Failure Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Heart Failure Drugs Revenue Market Share by Regions (2015-2020)
Figure 40. Global Heart Failure Drugs Revenue Market Share by Regions in 2018
Figure 41. North America Heart Failure Drugs Sales and Growth Rate (2015-2020)
Figure 42. Europe Heart Failure Drugs Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Heart Failure Drugs Sales and Growth Rate (2015-2020)
Figure 44. South America Heart Failure Drugs Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Heart Failure Drugs Sales and Growth Rate (2015-2020)
Figure 46. North America Heart Failure Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Heart Failure Drugs Sales Market Share by Countries (2015-2020)
Figure 48. North America Heart Failure Drugs Sales Market Share by Countries in 2018
Figure 49. North America Heart Failure Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Heart Failure Drugs Revenue Market Share by Countries in 2018
Figure 51. United States Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 52. Canada Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 53. Mexico Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 54. Europe Heart Failure Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Heart Failure Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Heart Failure Drugs Revenue Market Share by Countries in 2019
Figure 57. Germany Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 58. UK Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 59. France Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 60. Russia Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 61. Italy Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 62. Asia-Pacific Heart Failure Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Heart Failure Drugs Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Heart Failure Drugs Revenue Market Share by Regions 2019
Figure 65. China Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 66. Japan Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 67. Korea Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 68. India Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 69. Southeast Asia Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 70. South America Heart Failure Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Heart Failure Drugs Sales Market Share by Countries in 2019
Figure 72. South America Heart Failure Drugs Revenue Market Share by Countries in 2019
Figure 73. Brazil Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 74. Argentina Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 75. Middle East and Africa Heart Failure Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Heart Failure Drugs Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Heart Failure Drugs Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Heart Failure Drugs Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 80. Egypt Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 81. Turkey Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 82. South Africa Heart Failure Drugs Sales and Growth Rate (2015-2020) (MT)
Figure 83. Global Heart Failure Drugs Sales and Growth Rate (2021-2025) (MT)
Figure 84. Global Heart Failure Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Heart Failure Drugs Market Forecast (2021-2025) (MT)
Figure 86. Europe Sales Heart Failure Drugs Market Forecast (2021-2025) (MT)
Figure 87. Asia-Pacific Sales Heart Failure Drugs Market Forecast (2021-2025) (MT)
Figure 88. South America Sales Heart Failure Drugs Market Forecast (2021-2025) (MT)
Figure 89. Middle East & Africa Sales Heart Failure Drugs Market Forecast (2021-2025) (MT)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
急性心不全（AHF）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Acute Heart Failure (AHF) Therapeutics Market The global Acute Heart Failure (AHF) Therapeutics market size is projected to reach US$ 336 million by 2026, from US$ 262.2 million in 2020, at a CAGR of 26.8%% during 2021-2026. Global Acute Heart Failure (AHF) Thera…- 急性心不全（AHF）治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Acute Heart Failure (AHF) Therapeutics market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 25.7% in the forecast period of 2020 to 2025 and will expected to reach USD 672.8 million by 2025, from USD 269.8 million in 2019. Th…
- うっ血性心不全治療薬の世界市場（～2026年） Market Analysis and Insights: Global Congestive Heart Failure Drugs Market The global Congestive Heart Failure Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Congestive Heart Failure Drugs Scope and Market Size …
- 心不全監視ソフトウェアの世界市場（～2026年） Market Analysis and Insights: Global Heart Failure Mornitoring Software Market The global Heart Failure Mornitoring Software market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Heart Failure Mornitoring Software Scope and …
- うっ血性心不全（CHF）の世界市場（～2026年） Market Analysis and Insights: Global Congestive Heart Failure (CHF) Market The global Congestive Heart Failure (CHF) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Congestive Heart Failure (CHF) Scope and Market Size …